Myomo Reports Preliminary Fourth Quarter and Full Year 2020 Results
Fourth Quarter 2020 Revenue Expected to More than Double Compared With Fourth Quarter 2019 Quarterly cash utilization is the lowest since IPO in 2017 CAMBRIDGE, Mass. (January 11, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and […]
Myomo to Present H.C. Wainwright Virtual BioConnect 2021 Conference
CAMBRIDGE, Mass. (January 5, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, the Company’s chief executive officer, and David Henry, chief financial officer, will present at the H.C. Wainwright […]
Myomo to Present at Sidoti & Company Virtual Microcap Conference
CAMBRIDGE, Mass. (November 18, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that management will be presenting at the Sidoti & Company Virtual Microcap Conference on Thursday, November 19, 2020 at 1:45 […]
Myomo Introduces MyoGames™
Video Games Played via MyoPro for Training, Rehabilitation and Fun CAMBRIDGE, Mass. (November 16, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company offering increased functionality for individuals suffering from neurological disorders and upper-limb paralysis, announced today the availability of MyoGames by Lusio, a video game platform designed […]
Myomo Third Quarter Financial Results Feature Record Revenue of $1.9 Million, up 218% Over the Prior Year
Authorization backlog at a record 162 units, up 35% sequentially Cash utilization of $1.8 million, lowest since scale-up activities began in 2018 Conference call begins at 4:30 p.m. Eastern time today CAMBRIDGE, Mass. (November 10, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality […]
Myomo to Report Third Quarter Financial Results on November 10, 2020
Management to host Financial Results Conference Call at 4:30 p.m. ET CAMBRIDGE, Mass. (November 3, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it will report financial results for the […]
Myomo Appoints Dr. Harry Kovelman as Chief Medical Officer
Experienced Physician, Author and Executive to Join Senior Leadership TeamCAMBRIDGE, Mass. (November 2, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Harry Kovelman, MD, is joining the Company as its Chief […]
Myomo to Present at the MicroCap Rodeo Best Ideas Bowl on October 13, 2020
CAMBRIDGE, MA. / ACCESSWIRE (October 7, 2020) – Myomo, Inc. (NYSE American: MYO), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, has been invited to present at the MicroCap Rodeo Best Ideas Bowl, which is being held virtually on October 13th – 16th, 2020. Read […]
Myomo Certified as Medicare Provider – Authorization by Centers for Medicare & Medicaid Services Is One More Important Step
CAMBRIDGE, Mass. (September 15, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that the Centers for Medicare & Medicaid Services under the U.S. Department of Health and Human Services has authorized the Company […]
Myomo® to Present at the H.C. Wainwright Virtual 22nd Annual Global Investment Conference
CAMBRIDGE, Mass. (September 10, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that its management is scheduled to present at the H.C. Wainwright 22nd Annual Global Investment Conference to be held virtually on […]